| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
|
2
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
|
3
|
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.
|
Environ Health Perspect
|
2010
|
2.16
|
|
4
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
|
5
|
Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.
|
Haematologica
|
2006
|
1.64
|
|
6
|
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
|
PLoS Genet
|
2011
|
1.58
|
|
7
|
SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.
|
Blood
|
2011
|
1.57
|
|
8
|
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic.
|
Toxicol Sci
|
2008
|
1.54
|
|
9
|
Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.
|
Cancer Res
|
2003
|
1.53
|
|
10
|
Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
|
Blood
|
2002
|
1.46
|
|
11
|
Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.45
|
|
12
|
Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina.
|
Toxicol Appl Pharmacol
|
2010
|
1.30
|
|
13
|
Arsenic immunotoxicity: a review.
|
Environ Health
|
2013
|
1.27
|
|
14
|
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
|
Blood
|
2012
|
1.26
|
|
15
|
A generic coalescent-based framework for the selection of a reference panel for imputation.
|
Genet Epidemiol
|
2010
|
1.26
|
|
16
|
Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
|
Br J Haematol
|
2006
|
1.16
|
|
17
|
Integrating GWAS and expression data for functional characterization of disease-associated SNPs: an application to follicular lymphoma.
|
Am J Hum Genet
|
2012
|
1.14
|
|
18
|
Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.06
|
|
19
|
Molecular biomarkers for the study of childhood leukemia.
|
Toxicol Appl Pharmacol
|
2005
|
1.04
|
|
20
|
Benzene, the exposome and future investigations of leukemia etiology.
|
Chem Biol Interact
|
2011
|
1.01
|
|
21
|
Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk.
|
Am J Hum Genet
|
2013
|
1.00
|
|
22
|
Systems biology of human benzene exposure.
|
Chem Biol Interact
|
2009
|
0.99
|
|
23
|
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
|
Int J Cancer
|
2011
|
0.95
|
|
24
|
Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.
|
PLoS One
|
2012
|
0.94
|
|
25
|
Association of HLA-DQB1 alleles with risk of follicular lymphoma.
|
Leuk Lymphoma
|
2010
|
0.94
|
|
26
|
A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases.
|
Genomics
|
2011
|
0.90
|
|
27
|
Causal models of leukaemia and lymphoma.
|
IARC Sci Publ
|
2004
|
0.89
|
|
28
|
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
|
Blood
|
2012
|
0.89
|
|
29
|
Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism.
|
Environ Res
|
2010
|
0.88
|
|
30
|
Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism.
|
Proteomics
|
2007
|
0.88
|
|
31
|
Rare variant association testing under low-coverage sequencing.
|
Genetics
|
2013
|
0.88
|
|
32
|
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
|
Cancer Causes Control
|
2012
|
0.85
|
|
33
|
Chemokine polymorphisms and lymphoma: a pooled analysis.
|
Leuk Lymphoma
|
2010
|
0.84
|
|
34
|
RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia.
|
Leuk Res
|
2006
|
0.83
|
|
35
|
A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.
|
Int J Cancer
|
2011
|
0.81
|
|
36
|
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
|
Br J Haematol
|
2012
|
0.80
|
|
37
|
eALPS: estimating abundance levels in pooled sequencing using available genotyping data.
|
J Comput Biol
|
2013
|
0.79
|
|
38
|
Issues of processing and multiple testing of SELDI-TOF MS proteomic data.
|
Stat Appl Genet Mol Biol
|
2006
|
0.79
|
|
39
|
X chromosome-wide association study of follicular lymphoma.
|
Br J Haematol
|
2013
|
0.77
|
|
40
|
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development.
|
PLoS One
|
2013
|
0.75
|
|
41
|
Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
|
PLoS One
|
2013
|
0.75
|